Skip to main content
. 2022 Feb 21;8:793445. doi: 10.3389/fmolb.2021.793445

FIGURE 6.

FIGURE 6

CD93 expression and immune subtypes according to the Tumor–Immune System Interactions and Drug Bank (TISIDB) database. (A–F) Expression level of CD93 among different immune subtypes in six cancer types (LUSC, PRAD, LUAD, KIRC, LIHC, and BRCA).